Processa Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Processa Pharmaceuticals, Inc. (PCSA) on November 13, 2023, regarding an event that occurred on November 9, 2023. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and does not contain financial performance data.
Material Changes
The primary material change reported is the unexpected passing of Virgil Thompson, age 83, on November 9, 2023. Mr. Thompson served as a member of the Board of Directors and was the Chairman of the Nominating and Governance Committee.
Outlook, Risks, and Management Commentary
Management has stated that the Company does not have immediate plans to appoint a new member to the Board of Directors to replace Mr. Thompson. No other risks, contingencies, or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the date of the press release (Exhibit 99.1) confirming the death of Director Virgil Thompson.
- Monitor future filings for any updates regarding the appointment of a new Board member.
- Review the company's most recent 10-K or 10-Q for current financial status, as this 8-K contains no financial metrics.